Global Neurotrophic Keratitis Market is anticipated to expand at a CAGR of 5.1% from 2019 to 2027

The major symptoms associated with neurotrophic keratitis are red & dry eyes, blurred vision, pain, and discomfort in the eye. Approval of promising drugs such as Oxervate and TB4 is going to completely revolutionize the treatment regimen for neurotrophic keratitis during the forecast period. National Organization for Rare Disease has designated neurotrophic keratitis is a rare disease highlighting a prevalence rate of 5 per 10,000 people. The major causative agent is the herpes zoster virus and herpes simplex virus. The clinical manifestation of the disease is the progressive damage of nerve innervations…

Read More

Global Gait Rehabilitation System Market Is Expected to Grow At A CAGR of 8.2% from 2020 to 2027

According to the latest research citings provided by the world health organization (WHO), the prevalence rate of stroke in the Caucasian population is 500–600 per 100,000 people worldwide. A multidisciplinary approach is being utilized by physiotherapists in understanding the entire aspects of the physical and psychological requirements of ambulation in daily life multitasking. Gait trainer walkers are reigning the product type segment for the gait rehabilitation system market. The gait trainer walker can be custom made according to the age and ambulatory functions of the concerned individual. Research studies have…

Read More

Global Glaucoma Drugs Market is expected to grow at a CAGR of 4.0% from 2020 to 2027

According to the latest statistics provided by the International Agency for the Prevention of Blindness (IAPB) by 2020, approximately 3.2 million people will be reported blind due to glaucoma. Researchers are working on developing novel drug development for the treatment of glaucoma. Prostaglandins are spearheading the drug class segment for the glaucoma drug market. They are currently used as first-line therapy due to positive patient compliance as only a single dose is required daily, it acts by relaxing muscles of the eyes interior structure in order to promote fluid drainage…

Read More

Global Levobupivacaine Market is expected to grow at a CAGR of 3.5% from 2020 to 2027

Levobupivacaine is a long-acting local anesthetic agent belonging to the amido amine group, it is basically an S-enantiomer of bupivacaine drug. It has become popular among anesthesiologists worldwide owing to its less cardiotoxicity and motor blockade. It was primarily developed due to the reported incidents of seizures and cardiac arrests experienced due to the use of intravenous injection of bupivacaine. Significant rise in surgeries performed and increasing demand for post-operative pain management drive the levobupivacaine market growth. Epidural anesthesia is currently representing the largest market share in the levobupivacaine market.…

Read More

Global Protective Surgical Gowns Market Is Expected to Grow At A CAGR of 6.2% from 2020 to 2027

Protective surgical gowns are classified as a Class II medical device which requires a 510(k) premarket notification by the USFDA. The manufactures are engaged in the production of protective surgical gowns on the basis of its use as per the AAMI classification of 1-4 risk levels. Disposable gowns are representing the largest market share in the type segment for the protective surgical gowns market. The ergonomic features associated with disposable protective surgical gowns are cost-effectiveness and high safety assurance, there is no extra cost incurred for bleaching, disinfecting and conditioning,…

Read More

Global Swine Epidemic Diarrhea Vaccines Market Is Expected to Grow At A CAGR of 6.9% from 2020 to 2027

Porcine epidemic diarrhea virus is a large RNA enveloped virus which belongs to the Alphacoronavirus within the Coronaviridae. Highly virulent in its nature has an 80 to 100% mortality rate in neonatal pigs which causes huge economic burden to breeders and farmers across the globe. The current position is that very few players are active in the market which provides a tremendous opportunity for biopharmaceutical players engaged in veterinary health. Killed vaccines are representing the largest market share in the type segment for swine epidemic diarrhea vaccines market. The killed…

Read More

Global Dosulepin Market is expected to grow at a CAGR of 2.2% from 2020 to 2027

Dosulepin has a toxic profile and hence needs to be taken under medical supervision, The dosage regimen is oral administration of drug initially 25mg tid with a gradual increase to 50 mg tid, if need be the dose might be adjusted as a single dose of 225mg/day at night in cases of severe depression. Major depressive disorders currently reigning the largest market share in the dosulepin market. In this disease, the patient experiences low mood for at least 2 weeks which is usually accompanies by low self-esteem, lethargy, neuropsychic pain,…

Read More

Global Cisatracurium Besylate Market Is Expected To Grow At A CAGR Of 4.7% From 2020 To 2027

Cisatracurium besylate is classified as a non-depolarizing muscle relaxant which possesses intermediate onset and duration of action. It exerts its pharmacodynamic effect by competitively binding to the cholinergic receptors at the motor plate end causing blockade of neuromuscular transmission by antagonizing the action of acetylcholine. It gets degraded at physiological pH and temperature by the organ independent Hoffman elimination by forming the compound called laudanosine which gets further metabolized and finally excreted via urine. In the present scenario, the smooth muscle relaxant is spearheading the application segment for the cisatracurium…

Read More

Global Fibrinogen Market Is Expected to Grow At A CAGR of 8.0% from 2020 to 2027

Fibrinogen is a glycoprotein having a molecular weight of 340kDA, which is widely employed for its clinical application in treating bleeding disorders worldwide. The drug posology recommended when the fibrinogen blood levels are unknown is 70 mg/kg body weight, and the rate of injection should not exceed 5ml per minute. Congenital fibrinogen deficiency is representing the largest market share in the clinical application segment for the fibrinogen market. According to the latest statistics provided by the Orphanet Journal of Rare Diseases the global prevalence rate of congenital fibrinogen deficiency is…

Read More

Global Allergy Immunotherapy Market Is Expected to Grow At A CAGR of 9.8% from 2020 to 2027

As per the latest research citings provided by the World Health Organization (WHO), approximately 300 million people worldwide are suffering from asthma. Rising public health awareness regarding the therapeutic efficacy and safety associated with allergy immunotherapy will further accentuate its market growth. Subcutaneous immunotherapy is leading the treatment segment for allergy immunotherapy market. Subcutaneous injections are beneficial in achieving desired immunomodulation via 2 steps which are buildup phase which ranges from 3 to 6 months and then the maintenance phase which ranges from 2 to 4 weeks. They are manufacturers…

Read More